Form 4: Milestone Pharma CCO Gifts 25,000 Shares to Family

Sentiment:

Insider Transaction Report


Milestone Pharmaceuticals' Chief Commercial Officer, Lorenz Muller, reported gifting 25,000 common shares to family members.

Summary

  • Lorenz Muller, Chief Commercial Officer of Milestone Pharmaceuticals Inc. (MIST), reported a transaction involving the company's common shares.
  • On December 9, 2025, Muller disposed of 25,000 common shares.
  • The transaction was a bona fide gift for no consideration to members of his family residing outside his household.
  • Following this reported transaction, Muller directly beneficially owns 150,052 common shares.

Sentiment

Score: 5

Explanation: The filing reports a routine insider gift of shares, which is a neutral event regarding the company's operational performance or financial health. It does not inherently convey positive or negative sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual's personal financial planning rather than a corporate strategic move.

Related Party Transactions

  • Lorenz Muller, Chief Commercial Officer, gifted 25,000 common shares to members of his family outside his household for no consideration.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership, which is a common occurrence and generally has minimal impact on overall shareholder sentiment or company valuation.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
12/09/2025Date of transaction where 25,000 common shares were gifted.
12/11/2025Date the Statement of Changes in Beneficial Ownership (Form 4) was signed and filed.

Keywords

Milestone Pharmaceuticals, MIST, Insider Transaction, Form 4, Share Gift, Lorenz Muller, Chief Commercial Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.